India: PE firm ChrysCapital to buy Sequoia's 10% stake in GVK Bio for $25m

India: PE firm ChrysCapital to buy Sequoia's 10% stake in GVK Bio for $25m

Visual fro GVK Bio website

Pramugdha Mamgain

02 December, 2015

CadilaChrysCapitalDavinder BrarEris LifesciencesGVK BiosciencesIntasIpcaMankind PharmaRanbaxySanjay ReddySequoia Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.